Hellum KB - Search Results

1

Schrumpf E, Bjøro K, Bell H, Harthug S, Hellum KB, Myrvang B, Maeland A, Ritland S. Schrumpf E, et al. Among authors: hellum kb. Tidsskr Nor Laegeforen. 1996 Jun 10;116(15):1792-4. Tidsskr Nor Laegeforen. 1996. PMID: 8693463 Review. Norwegian.

2

[Treatment of chronic hepatitis C].

Bell H, Dalgard O, Bjøro K, Hellum KB, Myrvang B. Bell H, et al. Among authors: hellum kb. Tidsskr Nor Laegeforen. 2002 Apr 10;122(9):926-8. Tidsskr Nor Laegeforen. 2002. PMID: 12082838 Free article. Norwegian. No abstract available.

3

Prevalence of hepatitis C genotypes among patients with chronic hepatitis C in Norway. Construct Group.

Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K, Prescott L, Simmonds P. Bell H, et al. Scand J Infect Dis. 1996;28(4):357-9. doi: 10.3109/00365549609037919. Scand J Infect Dis. 1996. PMID: 8893398

4

Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Construct group.

Bell H, Hellum K, Harthug S, Maeland A, Ritland S, Myrvang B, von der Lippe B, Raknerud N, Skaug K, Gutigard BG, Skjaerven R, Prescott LE, Simmonds P. Bell H, et al. Scand J Infect Dis. 1997;29(1):17-22. doi: 10.3109/00365549709008658. Scand J Infect Dis. 1997. PMID: 9112292 Clinical Trial.

5

Treatment with interferon-alpha2a alone or interferon-alpha2a plus ribavirin in patients with chronic hepatitis C previously treated with interferon-alpha2a. CONSTRUCT Group.

Bell H, Hellum K, Harthug S, Myrvang B, Ritland S, Maeland A, von der Lippe B, Bjøro K, Skaug K, Gutigard BG, Raknerud N, Simmonds P. Bell H, et al. Scand J Gastroenterol. 1999 Feb;34(2):194-8. doi: 10.1080/00365529950173087. Scand J Gastroenterol. 1999. PMID: 10192200 Clinical Trial.

6

Treatment of chronic hepatitis C in injecting drug users: 5 years' follow-up.

Dalgard O, Bjøro K, Hellum K, Myrvang B, Skaug K, Gutigard B, Bell H; Construct Group. Dalgard O, et al. Eur Addict Res. 2002 Jan;8(1):45-9. doi: 10.1159/000049487. Eur Addict Res. 2002. PMID: 11818693

7

Thyroid dysfunction during treatment of chronic hepatitis C with interferon alpha: no association with either interferon dosage or efficacy of therapy.

Dalgard O, Bjøro K, Hellum K, Myrvang B, Bjøro T, Haug E, Bell H. Dalgard O, et al. J Intern Med. 2002 May;251(5):400-6. doi: 10.1046/j.1365-2796.2002.00974.x. J Intern Med. 2002. PMID: 11982739 Free article. Clinical Trial.

8

Effect of interferon-alpha induction therapy on genotype 2b/3a and low viral load hepatitis C virus infection. A randomized multicentre study.

Bjøro K, Bell H, Myrvang B, Skaug K, Raknerud N, Sandvei P, Størseth S, Ritland S, Lund-Tønnesen S, Bucher A, Hellum KB. Bjøro K, et al. Among authors: hellum kb. Scand J Gastroenterol. 2002 Mar;37(3):344-9. doi: 10.1080/003655202317284264. Scand J Gastroenterol. 2002. PMID: 11916198 Clinical Trial.

9

Raised serum ferritin predicts non-response to interferon and ribavirin treatment in patients with chronic hepatitis C infection.

Distante S, Bjøro K, Hellum KB, Myrvang B, Berg JP, Skaug K, Raknerud N, Bell H. Distante S, et al. Among authors: hellum kb. Liver. 2002 Jun;22(3):269-75. doi: 10.1046/j.0106-9543.2002.01672.x. Liver. 2002. PMID: 12100578

10

[A young, stuporous and afebrile man with icterus and nosebleed].

Strand EA, Strand ØA, Hellum KB, Smith-Erichsen N, Myrvang B. Strand EA, et al. Among authors: hellum kb. Tidsskr Nor Laegeforen. 2002 Feb 28;122(6):619-23. Tidsskr Nor Laegeforen. 2002. PMID: 11998715 Free article. Norwegian. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

60 results

Search Page